Newron Pharmaceuticals S.p.A. (0QOI.L)

LSE • Market Data in CHF, Fundamentals in EUR Market CHF / Fundamentals EUR

CHF 6.93

-CHF 0.04

-0.57%

Last Update: 17 Jul 2025, 12:56

CHF 138.33M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

CHF 4.12 - CHF 10.40

52 Week Range

0QOI.L Stock Price Chart

Explore Newron Pharmaceuticals S.p.A. interactive price chart. Choose custom timeframes to analyze 0QOI.L price movements and trends.

There is nothing to show.

0QOI.L Company Profile

Discover essential business fundamentals and corporate details for Newron Pharmaceuticals S.p.A. (0QOI.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

17 Jun 2014

Employees

22.00

Website

https://www.newron.com

CEO

Stefan Weber

Description

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

0QOI.L Financial Timeline

Browse a chronological timeline of Newron Pharmaceuticals S.p.A. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 14 Apr 2025

Earnings released on 19 Sept 2024

EPS came in at -CHF 0.50, while revenue for the quarter reached CHF 3.30M.

Earnings released on 19 Mar 2024

EPS came in at -CHF 0.49, while revenue for the quarter reached CHF 3.35M.

Earnings released on 30 Jun 2023

EPS came in at -CHF 0.38, while revenue for the quarter reached CHF 5.37M.

Earnings released on 31 Dec 2022

EPS came in at -CHF 0.49, while revenue for the quarter reached CHF 3.25M.

Earnings released on 30 Jun 2022

EPS came in at -CHF 0.48, while revenue for the quarter reached CHF 2.83M, missing expectations by -19.22%.

Earnings released on 31 Dec 2021

EPS came in at -CHF 0.34, while revenue for the quarter reached CHF 3.20M.

Earnings released on 30 Jun 2021

EPS came in at -CHF 0.56, while revenue for the quarter reached CHF 2.92M.

Earnings released on 31 Dec 2020

EPS came in at -CHF 0.64, while revenue for the quarter reached CHF 2.97M.

0QOI.L Stock Performance

Access detailed 0QOI.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.